2004 Access Conditions History 
Cannabis Law Report
JULY 2, 2022
Though it joined the European Union in 2004, Lithuania remained for several years the only country in the EU that criminalized even the cultivation of hemp – the non-psychoactive variety of the plant. As of yet, no patients in Lithuania have legal access to medical marijuana.
The Cannigma
OCTOBER 10, 2021
The history of cannabis in Greece can be traced back to the ancient Greeks and Romans, who used hemp fiber for boat sails, ropes, clothes, and much more. A survey carried out in 2004 found that 8.6% Would-be medical cannabis patients can gain access if they receive a prescription from a presiding physician.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canna Care Docs
NOVEMBER 23, 2020
Across these states, in different parts of the US, the message was clear: people recognize the benefits of legalization and want access to cannabis in their communities. The passing initiative legalizes cannabis prescriptions for 22 medical conditions. Medicinal cannabis was already approved in Montana in 2004.
Veriheal
JUNE 23, 2021
Like most recreational states preceding Montana in the move towards legalization, the state has had an existing medical marijuana (MMJ) program in place since 2004. Medical users are subject to lesser taxes but also have access to medical-exclusive locations, hours, products, and price specials.
The Cannigma
OCTOBER 8, 2021
The United Kingdom legalized medical cannabis in November 2018 but the program is the subject of criticism regarding access to medicine and approval of patients. The UK government made the decision i n 2004 to reclassify cannabis from a Class B to Class C drug, but the decision was rescinded in 2009. of those aged 16 to 24.
Cannabis Law Report
NOVEMBER 24, 2021
Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access.
Greencamp
AUGUST 16, 2018
The available body of evidence suggests that besides the lessening of symptoms, cannabis is also capable of slowing down the overall rate of progression of this horrible condition. Modern science hasn’t found a cure for this condition so far, and the most frequent cause of death is respiratory failure due to muscle decay.
Expert insights. Personalized for you.
52 
Let's personalize your content